Dados B3 › RECV3 × UGPA3
RECV3 × UGPA3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | RECV3 | UGPA3 | year |
|---|---|---|---|
| ROE | 14.9% | 15.9% | 2025 |
| ROIC | 11.0% | 12.1% | 2025 |
| ROA | 7.9% | 5.7% | 2025 |
| Gross margin | 32.3% | 6.6% | 2025 |
| EBIT margin | 22.9% | 3.5% | 2025 |
| Net margin | 20.2% | 1.8% | 2025 |
| Net debt/EBITDA | 0.84x | 2.26x | 2025 |
| Current ratio | 3.48x | 1.62x | 2025 |
| Revenue growth (1y) | -3.3% | 6.6% | 2025 |
| Revenue growth (5y CAGR) | 32.0% | 14.0% | 2025 |
| Piotroski F-Score | 5/9 | 4/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | RECV3 | UGPA3 | year |
|---|---|---|---|
| P/E | 6.31x | 11.46x | 2025 |
| P/B | 0.93x | 1.79x | 2025 |
| EV/EBITDA | 3.13x | 6.54x | 2025 |
| FCF yield | -3.4% | 12.3% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:24 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:24 UTC. If this does not match /saude, you are reading a cached copy.